Skip to main content

US ClosedU.S. Closed

TBPH: Theravance Biopharma Inc Stock Analysis | finqOS

Healthcare · Biotechnology

Theravance Biopharma, Inc. , a biopharmaceutical company, develops and commercializes medicines in the United States.

52W Range

50thpctl

Volume

0.75×avg

Market Cap

883.67MUSD

P/E Ratio

16.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Theravance Biopharma Inc

TBPHNASDAQ·USD·Closed

Theravance Biopharma Inc

TBPHNASDAQ·USD·Closed

$17.05

+0.06%

$17.05

+$0.01 (0.06%)

52W Range

50thpctl

Volume

0.75×avg

Mkt Cap

883.67MUSD

P/E

16.0TTM

Div Yield

–ann